Tongri Liu | Chief Representative
Allife Medicine

Tongri Liu, Chief Representative, Allife Medicine

Tongri Liu (Tony) has completed his Ph.D. at the age of 27 years from University of Oxford, UK. He is now the chief overseas representative of Beijing ALLIFE Medicine Science and Technology Co. Ltd., a Chinese Pharmaceutical Company specialised in iPSc derived cell and gene therapies, and the director of ALLIFE Medicine UK branch company and the UK subsediary company, iCell Therapeutics Ltd.. He has helped established the UK companies and is leading the clinical trial application with the MHRA in the UK for both iPSc-EPC and iPSc-Islet projects.

back to speakers